Apkudo Acquires Mobile reCell to Expand Enterprise Device Recovery
January 22, 2024
Apkudo has acquired Mobile reCell to strengthen its device lifecycle and enterprise take-back capabilities, integrating Mobile reCell as a new Enterprise Take-Back business unit. Mobile reCell's team (28 employees) and software-driven IT asset recovery platform will be folded into Apkudo's Circular Industry Platform; financial terms were not disclosed.
- Buyers
- Apkudo
- Targets
- Mobile reCell
- Industry
- IT Services
- Location
- Indiana, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Ookla Acquires CellRebel
July 27, 2022
Telecommunications
Seattle-based connectivity intelligence firm Ookla has acquired CellRebel, a Sweden-based telecom analytics company, to enhance Ookla’s consumer network experience insights and analytics capabilities. The deal adds CellRebel’s large-scale real-world measurement datasets and visualization tools to Ookla’s portfolio to better serve operators, CDNs, and other telecom customers worldwide.
-
Integra LifeSciences Acquires ACell, Inc.
December 16, 2020
Medical Devices
Integra LifeSciences agreed to acquire regenerative-medicine company ACell, Inc. for $300 million upfront in cash plus up to $100 million in revenue-based milestones. The acquisition adds ACell's MatriStem porcine urinary bladder matrix platform to Integra's tissue technologies portfolio and is expected to close in Q1 2021, subject to customary conditions.
-
Ziff Davis Acquires 1TwentyFour and CellRebel
October 4, 2022
Media & Entertainment
Ziff Davis, Inc. completed two acquisitions in Q3 2022, acquiring asset(s) related to 1TwentyFour (entertainment, U.S.) and an equity stake in CellRebel (connectivity, Sweden). Terms were not disclosed and the company said the transactions are not expected to be material to its financials; the deals expand Ziff Davis’ global customer base and product lineup.
-
Discovery Life Sciences Acquires AllCells
July 12, 2022
Biotechnology
Discovery Life Sciences has acquired AllCells to create an integrated, end-to-end provider of clinical-grade and RUO primary cell products and analytic services for the cell and gene therapy (CGT) continuum. The combined business — operating as AllCells, a Discovery Life Sciences Company and led by AllCells CEO Danny Zheng — aims to expand GMP-compliant starting materials, donor programs and multi‑omic characterization to accelerate CGT discovery through commercialization.
-
Lever Technology Acquires Retriever
February 22, 2023
Cloud & SaaS
Lever Technology has acquired Retriever, a bootstrapped enterprise SaaS and logistics platform that automates device returns for remote employees. Retriever, founded in 2021 by former Dropbox engineers Annie Kramer and Alex Sydell, has been profitable with strong growth and thousands of customers; FE International served as sell-side advisor.
-
Bio-Techne Acquires Namocell
June 22, 2022
Medical Devices
Bio-Techne Corporation has agreed to acquire Namocell, Inc., a Mountain View–based provider of single-cell sorting and dispensing platforms, with the deal expected to close in Bio-Techne's fiscal 2023 Q1. Namocell's Pala and Hana systems (installed base approaching 200 placements, ~60 sold in 2021) will complement Bio-Techne's Cell and Gene Therapy franchise and create commercial synergies across its analytical instruments sales force.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.